Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
21,338 total articles
Turbo Energy, a Nasdaq-listed company specializing in AI-driven solar energy storage and intelligent energy management, filed its FY2025 annual report showing 107% revenue growth to $23.46 million and a significant reduction in operating and net losses. The company is transitioning from a traditional energy storage provider to a technology-driven e…
Alpha Modus Holdings, Inc. (NASDAQ: AMOD) has launched Alpha Cash, a standalone fintech platform designed to serve millions of underbanked and unbanked Americans. Combining a mobile app with a physical retail kiosk infrastructure and AI-driven commerce, Alpha Cash aims to modernize financial access by enabling cash loading, peer-to-peer transfers, …
Myseum.AI, a privacy-focused AI and social media technology company, announced significant progress on its localized agentic AI platform. CEO Darin Myman detailed technological advancements, integration of Claude AI to accelerate platform development, and strategic growth initiatives including a new marketing hire and expansion into the wedding spa…
Safe Pro Group Inc., a Nasdaq-listed AI-enabled defense and security technology company, has been awarded an additional subcontract modification from a U.S. Government Prime Contractor. This extends support for their AI Edge Processing solution following a previous $1 million award, reinforcing the company's role in delivering cutting-edge AI-drive…
Teva Pharmaceuticals presented new data from the IMPACT-TD Registry showing that while 85% of young adults aged 18-29 with mood disorders experience moderate to severe impact from tardive dyskinesia (TD), only 23% have been formally diagnosed. The findings reveal significant diagnostic gaps and delays, with an average time of over 3.5 years to diag…
Terra Innovatum announced a strategic supply agreement with SPG Dry Cooling to provide a water-independent Air-Cooled Condenser for its SOLO™ Micro-Modular Reactor. This development advances the reactor’s deployment capability in water-constrained and remote locations, supporting scalable commercial rollouts and expanding the addressable market. Th…
BioVie Inc. announced the completion of its Phase 2 SUNRISE-PD trial evaluating the drug candidate bezisterim in early-stage Parkinson's disease patients. The study utilized a hybrid decentralized design to assess motor and non-motor symptoms, including inflammation and insulin resistance pathways. Topline data is expected in Q3 2026, which will in…
Kyverna Therapeutics has appointed Greg Martini as its new Chief Financial Officer effective May 18, 2026. Martini brings extensive financial leadership experience from his prior role as CFO at Ironwood Pharmaceuticals and will oversee financial operations as Kyverna advances its lead CAR T-cell therapy candidate, miv-cel, towards potential regulat…
StepStone Group Inc. has appointed Taylor Benson as the Head of U.S. Defined Contribution to lead the firm's new initiative focused on integrating diversified private markets exposure into retirement portfolios. This move targets growing demand from retirement plan sponsors and fiduciaries for private market solutions aligned with fiduciary governa…
Aeries Technology, a NASDAQ-listed company specializing in AI-driven business transformation for private equity portfolio companies, has introduced its new platform, A1 GCC. This AI-powered operations platform is designed to enhance the management of Global Capability Centers (GCC) by integrating planning, workforce management, governance, coordina…
Protara Therapeutics is hosting a virtual investor webinar to present an overview of lymphatic malformations (LMs), the current treatment landscape, regulatory designations, and clinical data supporting their investigational cell therapy TARA-002. The therapy has received several FDA designations including Rare Pediatric Disease and Breakthrough Th…
National Healthcare Properties, a healthcare-focused real estate investment trust, announced concurrent tender offers to repurchase up to $100 million aggregate purchase price of its 7.375% Series A and 7.125% Series B cumulative redeemable perpetual preferred stock at $22.50 per share. The offers commence May 18, 2026, expire June 16, 2026, and wi…
Enphase Energy has introduced its PowerMatch technology for IQ Battery 10C and 5P systems in the United States, Puerto Rico, Canada, Mexico, and select countries in Central America and the Caribbean. PowerMatch intelligently adjusts battery inverter operation in real-time to match home power usage, reducing energy losses and increasing efficiency. …
CareCloud, Inc. has fully redeemed its outstanding 8.75% Series B Preferred Stock using proceeds from a newly secured $50 million credit facility. This milestone marks the company's transition to a cleaner, more efficient capital structure, facilitating stronger cash flow and continued growth in its AI-powered healthcare technology platform. The co…
CPI Aerostructures, Inc. (NYSE American: CVU) announced robust first quarter 2026 financial results highlighting a 13% revenue increase to $17.4 million and a notable turnaround to $1.2 million net income compared to a net loss in Q1 2025. Gross profit margin expanded significantly due to a favorable product mix and operational efficiencies. Adjust…
CytomX Therapeutics announced the appointment of Mamata Gokhale, Ph.D., RAC, as Senior Vice President of Regulatory Affairs to lead global regulatory strategy and support the advancement of its PROBODY® pipeline, including the lead program Varseta-M towards potential approval and commercialization. Dr. Gokhale brings over 25 years of experience in …
Black Rock Coffee Bar announced that Cynosure acquired shares pledged by the founders to pay off their margin loan fully. Cynosure now holds approximately 13.6 million shares and intends to deepen its partnership with the company. Founders remain active shareholders and board members. The transaction underscores confidence in Black Rock Coffee Bar'…
Digital Realty has opened its first data center in Barcelona, known as BCN1, marking a strategic expansion in the Mediterranean region. Designed to support next-generation technologies such as AI and cloud computing, BCN1 enhances connectivity between key global areas and complements the firm's existing facilities on the Iberian Peninsula. Built wi…
Krystal Biotech, Inc. announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved VYJUVEK® (beremagene geperpavec-svdt) for treating wounds in dystrophic epidermolysis bullosa (DEB) patients from birth with COL7A1 gene mutations. This marks the first genetic medicine approval in the UK for DEB, complementing prior …
Outdoor Holding Company, owner of GunBroker.com and ammunition producer, announced a cash dividend of $0.546875 per share on its 8.75% Series A Cumulative Redeemable Perpetual Preferred Stock to be paid on June 15, 2026 to holders of record as of June 1, 2026.
Catheter Precision, Inc., a U.S.-based medical device company, announced a 200% revenue increase in Q1 2026 driven by strong growth in its electrophysiology products and the recently acquired aviation platform Flyte. The acquisition has enabled rapid scaling of Flyte's fleet and immediate revenue contribution, while the medical device segment conti…
Garrett Motion Inc. announced a successful repricing of its $635 million term loan due 2032, lowering the interest rate by 25 basis points to SOFR plus 175 basis points. The company also made an early repayment of $50 million to reduce debt, reflecting lender confidence and expected improvements in financial strength and liquidity.
Rein Therapeutics, a clinical-stage biotech focused on orphan pulmonary and fibrosis diseases, has closed an underwritten public offering raising $57.5 million. Proceeds will fully fund the ongoing Phase 2 trial of LTI-03 in idiopathic pulmonary fibrosis (IPF), support ongoing clinical and regulatory activities, and extend operational cash runway i…
Alignment Healthcare, a Medicare Advantage health services company focused on senior care, announced it will present at the prestigious Goldman Sachs Healthcare Conference, highlighting its growth and strategic initiatives in senior healthcare delivery.
Reviva Pharmaceuticals Holdings, a late-stage biopharmaceutical company focused on CNS, inflammatory, and cardiometabolic diseases, announced that its CEO, Laxminarayan Bhat, PhD, will participate in a fireside chat at A.G.P.'s Annual Healthcare Company Showcase. The company highlighted its pipeline, including two drug candidates, brilaroxazine and…
